BMJ Oncology
(Aug 2024)
Recall of ibrutinib and issues with therapeutic approval
- Alyson Haslam,
- Colton Lipfert,
- Myung Sun Kim,
- Vinay K Prasad
Affiliations
- Alyson Haslam
- Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA
- Colton Lipfert
- Columbia University, Manhattan, New York, USA
- Myung Sun Kim
- Compass Oncology, Portland, Oregon, USA
- Vinay K Prasad
- Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA
- DOI
-
https://doi.org/10.1136/bmjonc-2024-000418
- Journal volume & issue
-
Vol. 3,
no. 1
WeChat QR code